Invesaro

Stocks ABBV Earnings

Earnings

AbbVie Inc. (ABBV) earnings

Quarterly results of AbbVie Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when ABBV files with the SEC.

Next earnings date

AbbVie Inc. is expected to report around October 30, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) AbbVie Inc. reported revenue of $17B (+10.2% on the same quarter a year earlier) and net income of $3.6B (+285.2% on the same quarter a year earlier).

Diluted earnings per share were $2.03 (+290.4% on the same quarter a year earlier).

Filed with the SEC on August 3, 2026.

The latest results release

AbbVie updated its 2026 earnings guidance to reflect third-quarter acquired IPR&D and milestones expense.

The company expects third-quarter 2026 GAAP and adjusted non-GAAP earnings to include pre-tax acquired IPR&D and milestones expense of $216 million.

October 5, 2026 · Read the release explained

Revenue by quarter
Q3 24: $14.5B $14.5B Q3 24Q4 24: $15.1B $15.1B Q4 24Q1 25: $13.3B $13.3B Q1 25Q2 25: $15.4B $15.4B Q2 25Q3 25: $15.8B $15.8B Q3 25Q4 25: $16.6B $16.6B Q4 25Q1 26: $15B $15B Q1 26Q2 26: $17B $17B Q2 26
Net income by quarter
Q3 24: $1.6B $1.6B Q3 24Q4 24: -$22M -$22M Q4 24Q1 25: $1.3B $1.3B Q1 25Q2 25: $938M $938M Q2 25Q3 25: $186M $186M Q3 25Q4 25: $1.8B $1.8B Q4 25Q1 26: $695M $695M Q1 26Q2 26: $3.6B $3.6B Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$17B+10.2%$3.6B$2.03
Q1 FY2026March 31, 2026$15B+12.4%$695M$0.39
Q4 FY2025December 31, 2025$16.6B+10%$1.8B$1.02
Q3 FY2025September 30, 2025$15.8B+9.1%$186M$0.10
Q2 FY2025June 30, 2025$15.4B-$938M$0.52
Q1 FY2025March 31, 2025$13.3B-$1.3B$0.72
Q4 FY2024December 31, 2024$15.1B--$22M-$0.02
Q3 FY2024September 30, 2024$14.5B-$1.6B$0.88

Results filings

When is AbbVie Inc.'s next earnings date?

AbbVie Inc. is expected to report around October 30, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were AbbVie Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, AbbVie Inc. reported revenue of $17B and net income of $3.6B (+285.2% on the same quarter a year earlier). The figures come from its filing with the SEC.

Is AbbVie Inc.'s revenue growing?

Revenue in Q2 FY2026 was $17B, up 10.2% from $15.4B in the same quarter a year earlier.

Get an email when ABBV reports

Follow ABBV and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when ABBV files with the SEC.

Source: quarterly figures AbbVie Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about AbbVie Inc.